Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is -1.69% vs -3.28% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -6.56% vs -6.87% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is -1.69% vs -1.67% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 6.05% vs 11.27% in Mar 2025
Compare Balance Sheet Results of Emmessar Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
9.81
-4.81
-49.03%
Share Warrants & Outstandings
Total Reserve
3.12
-3.43
6.55
190.96%
Shareholder's Funds
8.11
6.38
1.73
27.12%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.28
0.00
0.28
0.00%
Other Long Term Liabilities
0.58
0.00
0.58
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.17
0.00
0.17
0.00%
Total Non-Current Liabilities
1.03
0.00
1.03
0.00%
Current Liabilities
Trade Payables
0.01
0.00
0.01
0.00%
Other Current Liabilities
0.15
0.09
0.06
66.67%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.48
0.00
0.48
0.00%
Total Current Liabilities
0.64
0.09
0.55
611.11%
Total Liabilities
9.78
6.47
3.31
51.16%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.05
0.00
2.05
0.00%
Less: Accumulated Depreciation
0.91
0.00
0.91
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.14
0.00
1.14
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.58
0.65
-0.07
-10.77%
Long Term Loans & Advances
0.00
0.17
-0.17
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
1.72
0.83
0.89
107.23%
Current Assets Loans & Advances
Current Investments
0.01
0.00
0.01
0.00%
Inventories
0.10
0.00
0.10
0.00%
Sundry Debtors
0.02
0.00
0.02
0.00%
Cash and Bank
7.32
0.07
7.25
10,357.14%
Other Current Assets
0.34
5.23
-4.89
-93.50%
Short Term Loans and Advances
0.28
0.33
-0.05
-15.15%
Total Current Assets
8.06
5.64
2.42
42.91%
Net Current Assets (Including Current Investments)
7.42
5.55
1.87
33.69%
Total Current Assets Excluding Current Investments
8.05
5.64
2.41
42.73%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.78
6.47
3.31
51.16%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
16.24
3.25
12.99
399.69%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.69% vs -3.28% in Mar 2025
Annual - Fixed Assets
Fixed Assets 1.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.56% vs -6.87% in Mar 2025
Annual - Investments
Investments 0.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.69% vs -1.67% in Mar 2025
Annual - Current Assets
Current Assets 8.06 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.05% vs 11.27% in Mar 2025